These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19426894)

  • 1. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage.
    Creutzfeldt CJ; Weinstein JR; Longstreth WT; Becker KJ; McPharlin TO; Tirschwell DL
    J Stroke Cerebrovasc Dis; 2009; 18(3):221-8. PubMed ID: 19426894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Platelet Transfusion on Intracerebral Hemorrhage in Patients on Antiplatelet Therapy-An Analysis Based on Intracerebral Hemorrhage Score.
    Arnone GD; Kumar P; Wonais MC; Esfahani DR; Campbell-Lee SA; Charbel FT; Amin-Hanjani S; Alaraj A; Seicean A; Mehta AI
    World Neurosurg; 2018 Mar; 111():e895-e904. PubMed ID: 29330079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency reversal of clopidogrel in the setting of spontaneous intracerebral hemorrhage.
    Campbell PG; Yadla S; Sen AN; Jallo J; Jabbour P
    World Neurosurg; 2011; 76(1-2):100-4; discussion 59-60. PubMed ID: 21839960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior Antiplatelet Therapy, Excluding Phosphodiesterase Inhibitor Is Associated with Poor Outcome in Patients with Spontaneous Intracerebral Haemorrhage.
    Liu ZH; Liu CH; Tu PH; Yip PK; Chen CC; Wang YC; Chen NY; Lin YS
    Transl Stroke Res; 2020 Apr; 11(2):185-194. PubMed ID: 31446619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytopenia and Clinical Outcomes in Intracerebral Hemorrhage: A Retrospective Multicenter Cohort Study.
    Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
    Stroke; 2021 Jan; 52(2):611-619. PubMed ID: 33430632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes.
    Khan NI; Siddiqui FM; Goldstein JN; Cox M; Xian Y; Matsouaka RA; Heidenreich PA; Peterson ED; Bhatt DL; Fonarow GC; Schwamm LH; Smith EE
    Stroke; 2017 Jul; 48(7):1810-1817. PubMed ID: 28596454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage.
    Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; DeRosa PA; Landes E; Lei S; Khandji J; Gutbrod S; Connolly ES
    Neurol Res; 2010 Sep; 32(7):706-10. PubMed ID: 20819399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual antiplatelet therapy reduces stroke but increases bleeding at the time of carotid endarterectomy.
    Jones DW; Goodney PP; Conrad MF; Nolan BW; Rzucidlo EM; Powell RJ; Cronenwett JL; Stone DH
    J Vasc Surg; 2016 May; 63(5):1262-1270.e3. PubMed ID: 26947237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
    Baharoglu MI; Cordonnier C; Al-Shahi Salman R; de Gans K; Koopman MM; Brand A; Majoie CB; Beenen LF; Marquering HA; Vermeulen M; Nederkoorn PJ; de Haan RJ; Roos YB;
    Lancet; 2016 Jun; 387(10038):2605-2613. PubMed ID: 27178479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior antiplatelet therapy is not associated with larger hematoma volume or hematoma growth in intracerebral hemorrhage.
    van Ginneken V; Engel P; Fiebach JB; Audebert HJ; Nolte CH; Rocco A
    Neurol Sci; 2018 Apr; 39(4):745-748. PubMed ID: 29441487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
    Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Prior Antiplatelet Therapy on the Prognosis of Primary Intracerebral Hemorrhage: A Meta-analysis.
    Yu HH; Pan C; Tang YX; Liu N; Zhang P; Hu Y; Zhang Y; Wu Q; Deng H; Li GG; Li YY; Nie H; Tang ZP
    Chin Med J (Engl); 2017 Dec; 130(24):2969-2977. PubMed ID: 29237930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activity and outcome after intracerebral hemorrhage.
    Naidech AM; Bernstein RA; Levasseur K; Bassin SL; Bendok BR; Batjer HH; Bleck TP; Alberts MJ
    Ann Neurol; 2009 Mar; 65(3):352-6. PubMed ID: 19334079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
    Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
    Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
    Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R;
    Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
    Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
    Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the Use of Platelet Transfusion in Patients with Intracerebral Hemorrhage: Observations from the Ethnic/Racial Variations of Intracerebral Hemorrhage Study.
    Guerrero WR; Gonzales NR; Sekar P; Kawano-Castillo J; Moomaw CJ; Worrall BB; Langefeld CD; Martini SR; Flaherty ML; Sheth KN; Osborne J; Woo D
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1974-1980. PubMed ID: 28669659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage.
    Xian Y; Zhang S; Inohara T; Grau-Sepulveda M; Matsouaka RA; Peterson ED; Piccini JP; Smith EE; Sheth KN; Bhatt DL; Fonarow GC; Schwamm LH
    JAMA Netw Open; 2021 Feb; 4(2):e2037438. PubMed ID: 33591368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in traumatic brain injury for patients presenting on antiplatelet therapy.
    Cull JD; Sakai LM; Sabir I; Johnson B; Tully A; Nagy K; Dennis A; Starr FL; Joseph K; Wiley D; Moore HR; Oliphant UJ; Bokhari F
    Am Surg; 2015 Feb; 81(2):128-32. PubMed ID: 25642873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage.
    Li Y; Liu X; Chen S; Wang J; Pan C; Li G; Tang Z
    CNS Neurosci Ther; 2023 Jun; 29(6):1484-1496. PubMed ID: 36942509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.